A Training Course on Drafting, Prosecution and Enforcement
Webcode 24111133
Dr. Leah Cueni Ortler
European and Swiss Patent Attorney, Chapter Lead Large Molecule IP, F. Hoffmann-La Roche, Basel (Switzerland)
Leah is a registered European and Swiss Patent Attorney with F. Hoffmann-La Roche AG which she joined as a patent attorney trainee in 2009. She is since 2022 a Senior Patent Attorney and Chapter Lead of the Large Molecule IP Group at the headquarters in Basel. Her focus areas are large molecules/biotechnology, oncology, cancer immunotherapy, and new therapeutic modalities. Leah is a pharmacist by training.
Dr. Jürgen Meier
German and European Patent Attorney, Vossius & Partner, Munich (Germany)
Jürgen is a partner at the IP firm Vossius & Partner and is a German and European Patent Attorney. He specializes in the drafting and prosecution of life sciences patents, oppositions, revocation proceedings as well as infringement proceedings relating to biotechnology and pharmaceuticals, with a special focus on biologicals, medical uses and fermentation technologies. He is, inter alia, the coeditor of the handbook 'Antibody Patenting: A Practitioner's Guide to Drafting, Prosecution and Enforcement'. Currently, he serves as chairman of the AIPPI Biotech Committee.
Oswin Ridderbusch
German and European Patent Attorney, Vossius & Partner, Munich (Germany)
Oswin is a German and European Patent Attorney and a partner at the IP law firm Vossius & Partner, with an academic background in medicinal chemistry and protein biochemistry. He specializes in the drafting and prosecution of patents in the fields of antibodies and biologics, small molecular pharmaceuticals, formulations, and diagnostics, as well as contentious post-grant proceedings and the filing of supplementary protection certificates.
More information please click here.
Amanda Murphy
PhD, Partner, U.S. Patent Attorney, Finnegan LLP, London (UK)
Amanda is a U.S. patent attorney with over 17 years of life sciences IP practice. She has substantial experience in, among others, antibodies and antibody drug conjugates. Amanda received her Ph.D. from Cornell University, where she studied the molecular requirements for protein-lipid interactions during retroviral assembly and the lipid compositions of retroviral particles.
07/11/2024
07/11/2024
7 November 2024 in Munich, from 09:00 - 17:00 CET
Veranstaltung - 1,380 € zzgl. MwSt.
The fee includes course documentation (including free download) as well as refreshments, lunch and a certificate. You will receive an invoice as well as a confirmation.
Veranstaltung - 1,380 € zzgl. MwSt.
The fee includes course documentation (including free download) as well as refreshments, lunch and a certificate. You will receive an invoice as well as a confirmation.
Jean-Claude Alexandre Ho, LL.M.
Lawyer, Conference Manager
+49 6221 500-675
jc.alexandreho@forum-institut.de
This one-day training course is about drafting, prosecuting and enforcing antibody patents, with a focus on European practice.
Antibodies have revolutionized medicine and biotechnology, and have become indispensable tools in therapy, diagnostics, analytics, and research. Therapeutic antibodies, for example, feature ever more prominently in the ranks of blockbuster drugs. At the same time, a body of case law dealing specifically with the patentability of antibody-related inventions and the enforcement of antibody patents has emerged in major jurisdictions. The, at times, significant divergences between different jurisdictions have been compounded by recent decisions in the United States, including the US Supreme Court decision in Amgen v. Sanofi of May 18, 2023, which have severely curtailed the possibilities to obtain broad antibody patents. It is therefore essential to understand how antibody inventions are assessed in different jurisdictions in order to secure an optimal patent protection and to successfully enforce such patents.
This training course is designed to provide a profound understanding of the patenting of antibodies, with a special focus on the EPO and a comparative overview of the practice in major American and Asian jurisdictions. Participants will gain valuable insights and practical advice covering all stages from initial drafting and prosecution to the litigation of antibody patents.
After the course, you will
Jürgen Meier, Oswin Ridderbusch and Amanda Murphy
Jürgen Meier and Oswin Ridderbusch
Leah Cueni Ortler
Oswin Ridderbusch and Amanda Murphy
of 5 stars of all ratings from 2023
of 5 stars on Trustpilot = good
Learn how to write digital patent applications which get granted and are infringed upon! This online course will give yo...
This online course aims at providing attendees with the mindset, the methodology and the tools to move a traditional IP ...
This topical in-person conference is about the latest developments in global patent litigation. Attendees will get insig...
This online course shall provide a sound overview about different local laws in important countries in EU and beyond wit...
Our speakers will give you tips and tricks on EP claim drafting and will show you which pitfalls to avoid.
Companies face different situations today when moving into a strategic approach to IP management. This white paper aims ...
Details
Download the checklist with typical patent license agreements clauses.
Details
Download the checklist with typical R&D agreements clauses.
Details
